EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan

---
EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan
Vote:
0 0
Previous VerifyVASP acquires Sygna, consolidating the global Travel Rule network
Next Blockchain.com Debuts Bespoke Wealth Program For Elite Investors & High-Volume Trading Clients

Related News

Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

The largest pharma show in Asia makes its return to Shanghai this June 2026

CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape

Xinhua Silk Road: E. China Jiangsu's Wuxi to strengthen economic, trade and cultural co-op with Japan

HYOSUNG Chairman Hyun-Joon Cho actively works for greater economic cooperation between Korea and Japan

menu
menu